Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 16, 2023 16:02 ET | Source: Shockwave Medical, Inc.

Shockwave Medical Reports Fourth Quarter and Full Year 2022 Financial Results

SANTA CLARA, Calif., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex...
January 31, 2023 08:00 ET | Source: Shockwave Medical, Inc.

Updated SCAI Guidance Includes Coronary IVL as a Treatment Option in All U.S. Catheterization Labs Regardless of Surgical Backup Status

SANTA CLARA, Calif., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified...
January 17, 2023 08:00 ET | Source: Shockwave Medical, Inc.

Shockwave Medical Announces Agreement to Acquire Neovasc

Neovasc’s Innovative Reducer System Will Target the Estimated $5 Billion Refractory Angina Market Shockwave Medical Announces Preliminary Fourth Quarter and Full Year 2022 Revenues and Full Year 2023...
January 04, 2023 16:05 ET | Source: Shockwave Medical, Inc.

Shockwave Medical Provides Quarterly Earnings Release Dates for 2023

SANTA CLARA, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex...
November 22, 2022 08:30 ET | Source: Shockwave Medical, Inc.

Shockwave Medical to Participate in the Piper Sandler 34th Annual Healthcare Conference

SANTA CLARA, Calif., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified...
November 16, 2022 08:30 ET | Source: Shockwave Medical, Inc.

Shockwave Medical Publishes Inaugural ESG Report

SANTA CLARA, Calif., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified...
November 07, 2022 16:03 ET | Source: Shockwave Medical, Inc.

Shockwave Medical Reports Third Quarter 2022 Financial Results

SANTA CLARA, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex...
November 01, 2022 14:45 ET | Source: Shockwave Medical, Inc.

Shockwave Confirms Consistent Outcomes for IVL in the Largest Prospective “Real World” Study of Patients with Heavily Calcified Peripheral Arterial Disease

LAS VEGAS, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular...
October 20, 2022 08:30 ET | Source: Shockwave Medical, Inc.

Shockwave Medical Announces Details for Conference Call Discussing Third Quarter 2022 Results

SANTA CLARA, Calif., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified...
September 19, 2022 09:00 ET | Source: Shockwave Medical, Inc.

Shockwave Medical Initiates All-Female Coronary IVL Study

EMPOWER CAD is the First Prospective, Female-Only Study of Coronary Interventions Study Seeks to Confirm Benefits of Shockwave’s Coronary IVL in Females Who Historically Have Suffered Less Favorable...